Smoking Cessation Aids Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Nicotine Replacement Therapy, Drugs, Electronic Cigarettes, and Others) and End-User (Hospital Pharmacies, Online Channel, Retail Pharmacies, and Other End Users)

Publication Month: Aug 2021 | Report Code: TIPRE00023325 | No. of Pages: 156 | Category: Pharmaceuticals | Status: Published

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!

The Smoking Cessation Aids market is expected to reach US$ 64,032.30 million in 2028 from US$ 23,413.08 million in 2021. The market is estimated to grow with a CAGR of 15.5% from 2021 to 2028.

Key factors that are driving the growth of this market are rising addiction toward tobacco smoking, increasing number of campaigns to reduce smoking and tobacco dependence. However, steeping costs for development of nicotine replacement therapies are likely to restrain the market growth in the future years to some extent.

 

Lucrative Regions for Smoking Cessation Aids Market

Lucrative Regions for Smoking Cessation Aids Market

Get more information on this report :

 

Market Insights


Rising addiction of tobacco smoking

Nicotine is a highly addictive substance found in tobacco plant. The smoking of tobacco is proven to be dangerous in all forms as it can lead to chronic health conditions, preventable diseases, deaths, and disabilities. According to the World Health Organization (WHO), smoking-related disorders result in about 435,000 deaths per year in the US, which equals to around 1 in 5 of the total deaths in the country. According to the Centers of Disease Control and Prevention (CDC), in 2018, nearly 40 million adults in the US smoked cigarettes. Moreover, about 4.7 million middle and high-school students used at least one tobacco product and around 1,600 young population below the age of 18 in the US smoked their first cigarettes. Every year, nearly half a million patients die due to illness caused by smoking. The US government spends ~US$ 225 billion for medical care to treat patients suffering from smoking-associated conditions in the US. Therefore, prevalence of tobacco smoking is high across various countries in the world.

The scenario is similar in various European and Asian countries. Greece, Bulgaria, France, and Croatia comprise the high tobacco consuming populations in Europe. According to the Institute of Health Metrics and Evaluation, smoking is a very common addiction in Europe as over 20% adults over the age of 15 smoke every day. Furthermore, according to the World Population Review, the highest smoking rates are found in Southeast Asia and Balkan in Europe. The WPR also suggests that in various South and Southeast Asian countries, the smoking rates tend to be high among men. For instance, in Indonesia, the smoking rate among males was 76.20% in 2018. Thus, the rising number of smoking populations across the world drives the growth of the global smoking cessation aids market.

 

Product-Based Insights

Based on product, the smoking cessation aids market is segmented into nicotine replacement therapy, drugs, electronic cigarettes, and others. E-cigarettes are considered as a healthy alternative to tobacco cigarettes and is estimated to be the fastest growing segment over the forecast period. E-cigarettes are an effective alternative for reducing health conditions associated with tobacco, while nicotine replacement therapies work best for smoking cessation. E-cigarettes are a potential threat to tobacco-based cigarettes. In addition, Consumption of e-cigarettes are less harmful compared to the regular cigarettes, no smoke and no risk of passive smoking, allowed to use even in no-smoking places, varying nicotine levels, and availability in various flavors are some of the major driving factors for the e-cigarettes market. in addition, the increasing popularity of e-cigarettes backed by its electronic feature is the major factor contributing towards its increasing demand.

 

Smoking Cessation Aids Market, by Product – 2021 and 2028

Smoking Cessation Aids Market, by Product – 2021 and 2028

Get more information on this report :


 

End User-Based Insights

Based on end-user, the smoking cessation aids market is segmented into hospital pharmacies, online channel, retail pharmacies, and other end users. The retail pharmacies segment is likely to hold the largest share of the market in 2021, however the online channel segment is anticipated to register the highest CAGR of the market during the forecast period.

 

Strategic Insights

The key players such as Pfizer Inc.; GlaxoSmithKline plc.; Dr. Reddy's Laboratories; Johnson and Johnson Services, Inc.; Cipla Inc.; Perrigo Company plc; Bausch Health Companies Inc.; Glenmark; NJOY; and Juul Labs adopt several organic and inorganic strategies to enhance their revenue and market standings. For instance, in July 2020, Dr Reddy’s Laboratories launched of over-the-counter Nicotine Polacrilex lozenges in the American market in the strengths of 2 mg and 4 mg. Moreover, in November 2020, Perrigo Company plc completed its the fourth year of its “Quitting is Better” campaign in partnership with the American Cancer Society (ACS).

 

Smoking Cessation Aids Market – by Product

  • Nicotine Replacement Therapy
  • Drugs
  • Electronic Cigarettes
  • Others

Smoking Cessation Aids Market – by End User

  • Hospital Pharmacies
  • Online Channel
  • Retail Pharmacies
  • Others

Smoking Cessation Aids Market – by Geography

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • UK
    • Spain
    • Rest of Europe
  • Asia Pacific (APAC)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Rest of Middle East &Africa
  • South and Central America (SCAM)
    • Brazil
    • Argentina
    • Rest of South and Central America

 

Company Profiles

  • Pfizer Inc.
  • GlaxoSmithKline plc.
  • Dr. Reddy's Laboratories
  • Johnson and Johnson Services, Inc.
  • Cipla Inc.
  • Perrigo Company plc
  • Bausch Health Companies Inc.
  • Glenmark
  • NJOY
  • Juul Labs

1.            Introduction

1.1       Scope of the Study

1.2       The Insight Partners Research Report Guidance

1.3       Market Segmentation

1.3.1        Global Smoking Cessation Aids Market – By Product

1.3.2        Global Smoking Cessation Aids Market – By End User

1.3.3        Global Smoking Cessation Aids Market – By Geography

2.            Smoking Cessation Aids Market – Key Takeaways

3.            Research Methodology

3.1       Coverage

3.2       Secondary Research

3.3       Primary Research

4.            Global Smoking Cessation Aids Market – Market Landscape

4.1       Overview

4.2       PEST Analysis

4.2.1        North America – PEST Analysis

4.2.2        Europe – PEST Analysis

4.2.3        Asia Pacific – PEST Analysis

4.2.4        Middle East and Africa (MEA) – PEST Analysis

4.2.5        South and Central America (SCAM) – PEST Analysis

4.3       Expert Opinions

5.            Smoking Cessation Aids Market – Key Market Dynamics

5.1       Market Drivers

5.1.1        Rising Addiction of Tobacco Smoking

5.1.2        Increasing Awareness Activities and Campaigns to Reduce Tobacco Usage and Dependence

5.2       Market Restraints

5.2.1        Steeping Costs for Development of Nicotine Replacement Therapies

5.3       Market Opportunities

5.3.1        E-cigarette Epidemic Among Youth

5.4       Future Trends

5.4.1        Introduction of New Smoking Cessation Aids

5.5       Impact Analysis

6.            Smoking Cessation Aids Market – Global Analysis

6.1       Global Smoking Cessation Aids Market Revenue Forecast and Analysis

6.2       Global Smoking Cessation Aids Market, By Geography - Forecast and Analysis

6.3       Market Positioning of Key Players

7.            Smoking Cessation Aids Market Analysis – By Product

7.1       Overview

7.2       Smoking Cessation Aids Market Revenue Share, by Product (2021 and 2028)

7.3       Nicotine Replacement Therapy

7.3.1        Overview

7.3.2        Nicotine Replacement Therapy: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (US$ Million)

7.4       Drugs

7.4.1        Overview

7.4.2        Drugs: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (US$ Million)

7.5       Electronic Cigarettes

7.5.1        Overview

7.5.2        Electronic Cigarettes: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (US$ Million)

7.6       Others

7.6.1        Overview

7.6.2        Others: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (US$ Million)

8.            Smoking Cessation Aids Market Analysis – By End-User

8.1       Overview

8.2       Smoking Cessation Aids Market Share, by End-User, 2021 and 2028, (%)

8.3       Hospital Pharmacies

8.3.1        Overview

8.3.2        Hospital Pharmacies: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (US$ Million)

8.4       Online Channel

8.4.1        Overview

8.4.2        Online Channel: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (US$ Million)

8.5       Retail Pharmacies

8.5.1        Overview

8.5.2        Retail Pharmacies: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (US$ Million)

8.6       Other End Users

8.6.1        Overview

8.6.2        Other End Users: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (US$ Million)

9.            Smoking Cessation Aids Market – Geographic Analysis

9.1       North America: Smoking Cessation Aids Market

9.1.1        Overview

9.1.2        North America: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)

9.1.3        North America: Smoking Cessation Aids Market, by Product, 2019–2028 (USD Million)

9.1.4        North America: Smoking Cessation Aids Market, by End User, 2019–2028 (USD Million)

9.1.5        North America: Smoking Cessation Aids Market, by Country, 2021 & 2028 (%)

9.1.5.1      US: Smoking Cessation Aids Market– Revenue and Forecast to 2028 (USD Million)

9.1.5.1.1      US: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)

9.1.5.1.2      US: Smoking Cessation Aids Market, by Product, 2019–2028 (USD Million)

9.1.5.1.3      US: Smoking Cessation Aids Market, by End User, 2019–2028 (USD Million)

9.1.5.2      Canada: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)

9.1.5.2.1      Canada: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)

9.1.5.2.2      Canada: Smoking Cessation Aids Market, by Product, 2019–2028 (USD Million)

9.1.5.2.3      Canada: Smoking Cessation Aids Market, by End User, 2019–2028 (USD Million)

9.1.5.3      Mexico: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)

9.1.5.3.1      Mexico: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)

9.1.5.3.2      Mexico: Smoking Cessation Aids Market, by Product – 2019–2028 (USD Million)

9.1.5.3.3      Mexico: Smoking Cessation Aids Market, by End User – 2019–2028 (USD Million)

9.2       Europe: Smoking Cessation Aids Market

9.2.1        Overview

9.2.2        Europe: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)

9.2.3        Europe: Smoking Cessation Aids Market, by Product, 2019–2028 (USD Million)

9.2.4        Europe: Smoking Cessation Aids Market, End User, 2019–2028 (USD Million)

9.2.5        Europe: Smoking Cessation Aids Market, by Country, 2021 & 2028 (%)

9.2.5.1      Germany: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)

9.2.5.1.1      Germany: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)

9.2.5.1.2      Germany: Smoking Cessation Aids Market, by Product, 2019–2028 (USD Million)

9.2.5.1.3      Germany: Smoking Cessation Aids Market, End User, 2019–2028 (USD Million)

9.2.5.2      France: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)

9.2.5.2.1      France: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)

9.2.5.2.2      France: Smoking Cessation Aids Market, by Product, 2019–2028 (USD Million)

9.2.5.2.3      France: Smoking Cessation Aids Market, End User– 2019–2028 (USD Million)

9.2.5.3      UK: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)

9.2.5.3.1      UK: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)

9.2.5.3.2      UK: Smoking Cessation Aids Market, by Product, 2019–2028 (USD Million)

9.2.5.3.3      UK: Smoking Cessation Aids Market, End User, 2019–2028 (USD Million)

9.2.5.4      Italy: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)

9.2.5.4.1      Italy: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)

9.2.5.4.2      Italy: Smoking Cessation Aids Market, by Product, 2019–2028 (USD Million)

9.2.5.4.3      Italy: Smoking Cessation Aids Market, End User, 2019–2028 (USD Million)

9.2.5.5      Spain: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)

9.2.5.5.1      Spain: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)

9.2.5.5.2      Spain: Smoking Cessation Aids Market, by Product, 2019–2028 (USD Million)

9.2.5.5.3      Spain: Smoking Cessation Aids Market, End User, 2019–2028 (USD Million)

9.2.5.6      Rest of Europe: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)

9.2.5.6.1      Rest of Europe: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)

9.2.5.6.2      Rest of Europe: Smoking Cessation Aids Market, by Product, 2019–2028 (USD Million)

9.2.5.6.3      Rest of Europe: Smoking Cessation Aids Market, by End User, 2019–2028 (USD Million)

9.1       Asia Pacific: Smoking Cessation Aids Market

9.1.1        Overview

9.1.2        Asia Pacific: Smoking Cessation Aids Market - Revenue and Forecast to 2028 (USD Million)

9.1.3        Asia Pacific: Smoking Cessation Aids Market, by Product, 2019–2028 (USD Million)

9.1.4        Asia Pacific: Smoking Cessation Aids Market, by End-User, 2019–2028 (USD Million)

9.1.5        Asia Pacific: Smoking Cessation Aids Market, by Country, 2021 & 2028 (%)

9.1.6        China: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)

9.1.6.1      China: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)

9.1.6.2      China: Smoking Cessation Aids Market, by Product, 2019–2028 (USD Million)

9.1.6.3      China: Smoking Cessation Aids Market, by End User, 2019–2028 (USD Million)

9.1.7        Japan: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)

9.1.7.1      Japan: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)

9.1.7.2      Japan: Smoking Cessation Aids Market, by Product, 2019–2028 (USD Million)

9.1.7.3      Japan: Smoking Cessation Aids Market, by End User, 2019–2028 (USD Million)

9.1.8        India: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)

9.1.8.1      India: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)

9.1.8.2      India: Smoking Cessation Aids Market, by Product, 2019–2028 (USD Million)

9.1.8.3      India: Smoking Cessation Aids Market, by End User, 2019–2028 (USD Million)

9.1.9        Australia: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)

9.1.9.1      Australia: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)

9.1.9.2      Australia: Smoking Cessation Aids Market, by Product, 2019–2028 (USD Million)

9.1.9.3      Australia: Smoking Cessation Aids Market, by End User, 2019–2028 (USD Million)

9.1.10     South Korea: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)

9.1.10.1   South Korea: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)

9.1.10.2   South Korea: Smoking Cessation Aids Market, by Product, 2019–2028 (USD Million)

9.1.10.3   South Korea: Smoking Cessation Aids Market, by End User, 2019–2028 (USD Million)

9.1.11     Rest of Asia Pacific: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)

9.1.11.1   Rest of Asia Pacific: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)

9.1.11.2   Rest of Asia Pacific: Smoking Cessation Aids Market, by Product, 2019–2028 (USD Million)

9.1.11.3   Rest of Asia Pacific: Smoking Cessation Aids Market, by End User, 2019–2028 (USD Million)

9.2       Middle East & Africa: Smoking Cessation Aids Market

9.2.1        Overview

9.2.2        Middle East & Africa: Smoking Cessation Aids Market - Revenue and Forecast to 2028 (US$ Million)

9.2.3        Middle East and Africa Smoking Cessation Aids Market, by Product– Revenue and Forecast to 2028 (USD Million)

9.2.4        Middle East and Africa Smoking Cessation Aids Market, by End-User– Revenue and Forecast to 2028 (USD Million)

9.2.5        Middle East & Africa: Smoking Cessation Aids Market, by Country, 2021 & 2028 (%)

9.2.6        Saudi Arabia: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)

9.2.6.1      Saudi Arabia: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)

9.2.6.2      Saudi Arabia Smoking Cessation Aids Market, by Product– Revenue and Forecast to 2028 (USD Million)

9.2.6.3      Saudi Arabia Smoking Cessation Aids Market, by End-User– Revenue and Forecast to 2028 (USD Million)

9.2.7        UAE: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)

9.2.7.1      UAE: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)

9.2.7.2      UAE Smoking Cessation Aids Market, by Product– Revenue and Forecast to 2028 (USD Million)

9.2.7.3      UAE Smoking Cessation Aids Market, by End-User– Revenue and Forecast to 2028 (USD Million)

9.2.8        South Africa: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)

9.2.8.1      South Africa: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)

9.2.8.2      South Africa Smoking Cessation Aids Market, by Product– Revenue and Forecast to 2028 (USD Million)

9.2.8.3      South Africa Smoking Cessation Aids Market, by End-User– Revenue and Forecast to 2028 (USD Million)

9.2.9        Rest of Middle East and Africa: Smoking Cessation Aids Market – Revenue and Forecast to 2028  (USD Million)

9.2.9.1      Rest of Middle East and Africa: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)

9.2.9.2      Rest of Middle East and Africa Smoking Cessation Aids Market, by Product– Revenue and Forecast to 2028 (USD Million)

9.2.9.3      Rest of Middle East and Africa Smoking Cessation Aids Market, by End-User– Revenue and Forecast to 2028  (USD Million)

9.3       South and Central America: Smoking Cessation Aids Market

9.3.1        Overview

9.3.2        South and Central America: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)

9.3.3        South and Central America: Smoking Cessation Aids Market, by Product, 2019–2028 (USD Million)

9.3.4        South and Central America: Smoking Cessation Aids Market, End User, 2019–2028 (USD Million)

9.3.5        South and Central America: Smoking Cessation Aids Market, by Country, 2021 & 2028 (%)

9.3.5.1      Brazil: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)

9.3.5.1.1      Brazil: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)

9.3.5.1.2      Brazil: Smoking Cessation Aids Market, by Product, 2019–2028 (USD Million)

9.3.5.1.3      Brazil: Smoking Cessation Aids Market, End User, 2019–2028 (USD Million)

9.3.5.2      Argentina: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)

9.3.5.2.1      Argentina: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)

9.3.5.2.2      Argentina: Smoking Cessation Aids Market, by Product, 2019–2028 (USD Million)

9.3.5.2.3      Argentina: Smoking Cessation Aids Market, End User, 2019–2028 (USD Million)

9.3.5.3      Rest of South and Central America: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)

9.3.5.3.1      Rest of South and Central America: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)

9.3.5.3.2      Rest of South and Central America: Smoking Cessation Aids Market, by Product, 2019–2028 (USD Million)

9.3.5.3.3      Rest of South and Central America: Smoking Cessation Aids Market, End User, 2019–2028 (USD Million)

10.         Impact of COVID-19 Pandemic on Global Smoking Cessation Aids Market

10.1    North America: Impact Assessment of COVID-19 Pandemic

10.2    Europe: Impact Assessment Of COVID-19 Pandemic

10.3    Asia-Pacific: Impact Assessment of COVID-19 Pandemic

10.4    Middle East & Africa: Impact Assessment of COVID-19 Pandemic

10.5    South and Central America: Impact Assessment of COVID-19 Pandemic

11.         Industry Landscape

11.1    Overview

11.2    Growth Strategies Done by the Companies in the Market, (%)

11.3    Organic Developments

11.3.1     Overview

11.4    Inorganic Developments

11.4.1     Overview

12.         Company Profiles

12.1    Pfizer Inc.

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Products and Services

12.1.4     Financial Overview

12.1.5     SWOT Analysis

12.1.6     Key Developments

12.2    GlaxoSmithKline plc.

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Products and Services

12.2.4     Financial Overview

12.2.5     SWOT Analysis

12.2.6     Key Developments

12.3    Dr. Reddy's Laboratories

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Products and Services

12.3.4     Financial Overview

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4    Johnson and Johnson Services, Inc.

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Products and Services

12.4.4     Financial Overview

12.4.5     SWOT Analysis

12.4.6     Key Developments

12.5    Cipla Inc.

12.5.1     Key Facts

12.5.2     Business Description

12.5.3     Products and Services

12.5.4     Financial Overview

12.5.5     SWOT Analysis

12.5.6     Key Developments

12.6    Perrigo Company plc

12.6.1     Key Facts

12.6.2     Business Description

12.6.3     Products and Services

12.6.4     Financial Overview

12.6.5     SWOT Analysis

12.6.6     Key Developments

12.7    Bausch Health Companies Inc.

12.7.1     Key Facts

12.7.2     Business Description

12.7.3     Products and Services

12.7.4     Financial Overview

12.7.5     SWOT Analysis

12.7.6     Key Developments

12.8    Glenmark

12.8.1     Key Facts

12.8.2     Business Description

12.8.3     Products and Services

12.8.4     Financial Overview

12.8.5     SWOT Analysis

12.8.6     Key Developments

12.9    NJOY

12.9.1     Key Facts

12.9.2     Business Description

12.9.3     Products and Services

12.9.4     Financial Overview

12.9.5     SWOT Analysis

12.9.6     Key Developments

12.10 Juul Labs

12.10.1   Key Facts

12.10.2   Business Description

12.10.3   Products and Services

12.10.4   Financial Overview

12.10.5   SWOT Analysis

12.10.6   Key Developments

13.         Appendix

13.1    About The Insight Partners

13.2       Glossary of Terms

LIST OF TABLES

Table 1.            Countries with Highest Number of Smokers Worldwide in 2021

Table 2.            North America Smoking Cessation Aids Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 3.            North America Smoking Cessation Aids Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 4.            US Smoking Cessation Aids Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 5.            US: Smoking Cessation Aids Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 6.            Canada Smoking Cessation Aids Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 7.            Canada Smoking Cessation Aids Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 8.            Mexico Smoking Cessation Aids Market, by Product– Revenue and Forecast to 2028 (USD Million)

Table 9.            Mexico Smoking Cessation Aids Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 10.          Europe: Smoking Cessation Aids Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 11.          Europe: Smoking Cessation Aids Market, End User – Revenue and Forecast to 2028 (USD Million)

Table 12.          Germany: Smoking Cessation Aids Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 13.          Germany: Smoking Cessation Aids Market, End User – Revenue and Forecast to 2028 (USD Million)

Table 14.          France: Smoking Cessation Aids Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 15.          France: Smoking Cessation Aids Market, End User– Revenue and Forecast to 2028 (USD Million)

Table 16.          UK: Smoking Cessation Aids Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 17.          UK: Smoking Cessation Aids Market, End User– Revenue and Forecast to 2028 (USD Million)

Table 18.          Italy: Smoking Cessation Aids Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 19.          Italy: Smoking Cessation Aids Market, End User – Revenue and Forecast to 2028 (USD Million)

Table 20.          Spain: Smoking Cessation Aids Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 21.          Spain: Smoking Cessation Aids Market, End User – Revenue and Forecast to 2028 (USD Million)

Table 22.          Rest of Europe: Smoking Cessation Aids Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 23.          Rest of Europe: Smoking Cessation Aids Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 24.          Asia Pacific: Smoking Cessation Aids Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 25.          Asia Pacific Smoking Cessation Aids Market, by End-User – Revenue and Forecast to 2028 (USD Million)

Table 26.          China: Smoking Cessation Aids Market, by Product– Revenue and Forecast to 2028 (USD Million)

Table 27.          China: Smoking Cessation Aids Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 28.          Japan: Smoking Cessation Aids Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 29.          Japan: Smoking Cessation Aids Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 30.          India: Smoking Cessation Aids Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 31.          India: Smoking Cessation Aids Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 32.          Australia: Smoking Cessation Aids Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 33.          Australia: Smoking Cessation Aids Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 34.          South Korea: Smoking Cessation Aids Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 35.          South Korea: Smoking Cessation Aids Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 36.          Rest of Asia Pacific: Smoking Cessation Aids Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 37.          Rest of Asia Pacific: Smoking Cessation Aids Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 38.          Middle East and Africa Smoking Cessation Aids Market, by Product– Revenue and Forecast to 2028  (USD Million)

Table 39.          Middle East and Africa Smoking Cessation Aids Market, by End-User– Revenue and Forecast to 2028  (USD Million)

Table 40.          Saudi Arabia Smoking Cessation Aids Market, by Product– Revenue and Forecast to 2028 (USD Million)

Table 41.          Saudi Arabia Smoking Cessation Aids Market, by End-User– Revenue and Forecast to 2028 (USD Million)

Table 42.          UAE Smoking Cessation Aids Market, by Product– Revenue and Forecast to 2028 (USD Million)

Table 43.          UAE Smoking Cessation Aids Market, by End-User– Revenue and Forecast to 2028 (USD Million)

Table 44.          South Africa Smoking Cessation Aids Market, by Product– Revenue and Forecast to 2028 (USD Million)

Table 45.          South Africa Smoking Cessation Aids Market, by End-User– Revenue and Forecast to 2028 (USD Million)

Table 46.          Rest of Middle East and Africa Smoking Cessation Aids Market, by Product– Revenue and Forecast to 2028 (USD Million)

Table 47.          Rest of Middle East and Africa Smoking Cessation Aids Market, by End-User– Revenue and Forecast to 2028 (USD Million)

Table 48.          South and Central America: Smoking Cessation Aids Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 49.          South and Central America: Smoking Cessation Aids Market, End User – Revenue and Forecast to 2028 (USD Million)

Table 50.          Brazil: Smoking Cessation Aids Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 51.          Brazil: Smoking Cessation Aids Market, End User – Revenue and Forecast to 2028 (USD Million)

Table 52.          Argentina: Smoking Cessation Aids Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 53.          Argentina: Smoking Cessation Aids Market, End User – Revenue and Forecast to 2028 (USD Million)

Table 54.          Rest of South and Central America: Smoking Cessation Aids Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 55.          Rest of South and Central America: Smoking Cessation Aids Market, End User – Revenue and Forecast to 2028 (USD Million)

Table 56.          Organic Developments Done By Companies

Table 57.          Inorganic Developments Done By Companies

Table 58.          Glossary of Terms, Smoking Cessation Aids Market

LIST OF FIGURES

Figure 1.           Smoking Cessation Aids Market Segmentation

Figure 2.           Smoking Cessation Aids Market Segmentation, By Region

Figure 3.           Smoking Cessation Aids Market Overview

Figure 4.           Electronic Cigarettes Segment Held Largest Share of Smoking Cessation Aids Market

Figure 5.           APAC to Show Significant Growth During Forecast Period

Figure 6.           Smoking Cessation Aids Market, by Geography (US$ Million)

Figure 7.           Global Smoking Cessation Aids Market – Leading Country Markets (US$ Million)

Figure 8.           Global Smoking Cessation Aids Market, Industry Landscape

Figure 9.           North America PEST Analysis

Figure 10.        Europe PEST Analysis

Figure 11.        Asia Pacific PEST Analysis

Figure 12.        Middle East and Africa (MEA) PEST Analysis

Figure 13.        South and Central America (SCAM) PEST Analysis

Figure 14.        Smoking Cessation Aids Market Impact Analysis of Drivers and Restraints

Figure 15.        Global Smoking Cessation Aids Market – Revenue Forecast and Analysis – 2020- 2028

Figure 16.        Global Smoking Cessation Aids Market – By Geography Forecast and Analysis – 2021- 2028

Figure 17.        Market Positioning of Key Players in Global Smoking Cessation Aids Market

Figure 18.        Smoking Cessation Aids Market Revenue Share, by Product (2021 and 2028)

Figure 19.        Nicotine Replacement Therapy: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20.        Drugs: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21.        Electronic Cigarettes: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22.        Others: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23.        Smoking Cessation Aids Market Share, by End-User, 2021 and 2028 (%)

Figure 24.        Hospital Pharmacies: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25.        Online Channel: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26.        Retail Pharmacies: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27.        Other End Users: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (US$ Million)

Figure 28.        North America: Smoking Cessation Aids Market, by Key Country – Revenue (2021) (USD Million)

Figure 29.        North America Smoking Cessation Aids Market Revenue and Forecast to 2028 (USD Million)

Figure 30.        North America: Smoking Cessation Aids Market, by Country, 2021 & 2028 (%)

Figure 31.        US: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)

Figure 32.        Canada: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)

Figure 33.        Mexico: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)

Figure 34.        Europe: Smoking Cessation Aids Market, by Key Country – Revenue (2021) (USD Million)

Figure 35.        Europe: Smoking Cessation Aids Market Revenue and Forecast to 2028 (USD Million)

Figure 36.        Europe: Smoking Cessation Aids Market, by Country, 2021 & 2028 (%)

Figure 37.        Germany: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)

Figure 38.        France: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)

Figure 39.        UK: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)

Figure 40.        Italy: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)

Figure 41.        Spain: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)

Figure 42.        Rest of Europe: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)

Figure 43.        Asia Pacific: Smoking Cessation Aids Market, by Key Country – Revenue (2021) (USD Million)

Figure 44.        Asia Pacific Smoking Cessation Aids Market Revenue and Forecast to 2028 (USD Million)

Figure 45.        Asia Pacific: Smoking Cessation Aids Market, by Country, 2021 & 2028 (%)

Figure 46.        China: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)

Figure 47.        Japan: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)

Figure 48.        India: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)

Figure 49.        Australia: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)

Figure 50.        South Korea: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)

Figure 51.        Rest of Asia Pacific: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)

Figure 52.        Middle East & Africa: Smoking Cessation Aids Market, by Key Country – Revenue (2021) (USD Million)

Figure 53.        Middle East & Africa Smoking Cessation Aids Market Revenue and Forecast to 2028 (USD Million)

Figure 54.        Middle East & Africa: Smoking Cessation Aids Market, by Country, 2021 & 2028 (%)

Figure 55.        Saudi Arabia: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)

Figure 56.        UAE: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)

Figure 57.        South Africa: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)

Figure 58.        Rest of Middle East and Africa: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)

Figure 59.        South and Central America: Smoking Cessation Aids Market, by Key Country – Revenue (2021) (USD Million)

Figure 60.        South and Central America: Smoking Cessation Aids Market Revenue and Forecast to 2028 (USD Million)

Figure 61.        South and Central America: Smoking Cessation Aids Market, by Country, 2021 & 2028 (%)

Figure 62.        Brazil: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)

Figure 63.        Argentina: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)

Figure 64.        Rest of South and Central America: Smoking Cessation Aids Market – Revenue and Forecast to 2028 (USD Million)

Figure 65.        Impact of COVID-19 Pandemic in North American Country Markets

Figure 66.        Impact of COVID-19 Pandemic in European Country Markets

Figure 67.        Impact of COVID-19 Pandemic in Asia Pacific Country Markets

Figure 68.        Impact Of COVID-19 Pandemic In Middle East & Africa Market

Figure 69.        Impact Of COVID-19 Pandemic In South and Central America Countries Market

Figure 70.        Growth Strategies Done by the Companies in the Market, (%)

 

The List of Companies - Smoking Cessation Aids Market

  1. Pfizer Inc.
  2. GlaxoSmithKline plc.
  3. Dr. Reddy's Laboratories
  4. Johnson and Johnson Services, Inc.
  5. Cipla Inc.
  6. Perrigo Company plc
  7. Bausch Health Companies Inc.
  8. Glenmark
  9. NJOY
  10. Juul Labs
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Smoking Cessation Aids Market.

 

  • Highlights key business priorities in order to assist companies to realign their business strategies.

 

  • The key findings and recommendations highlight crucial progressive industry trends in the global Smoking Cessation Aids, thereby allowing players across the value chain to develop effective long-term strategies.

 

  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

 

  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

 

  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
TIPRE00023325
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Frequently Asked Questions

Smoking cessation lowers the risk of cancer and other serious health problems. Some products contain nicotine as an active ingredient and others do not. Counseling, behavior therapy, medicines, and nicotine-containing products, such as nicotine patches, gum, lozenges, inhalers, and nasal sprays, may be used to help a person quit smoking.

The factors that are driving and restraining factors that will affect Smoking Cessation Aids Market in the coming years. Factors such as rising addiction toward tobacco smoking, increasing number of campaigns to reduce smoking and tobacco dependence. However, steeping costs for development of nicotine replacement therapies are likely to restrain the market growth in the future years to some extent.

The Smoking Cessation Aids Market majorly consists of the players such as Pfizer Inc., GlaxoSmithKline plc., Dr. Reddy's Laboratories, Johnson and Johnson Services, Inc., Cipla Inc., Perrigo Company plc, Bausch Health Companies Inc., Glenmark, NJOY, Juul Labs among others amongst others.

The US is the largest market for Smoking Cessation Aids at a global level. The market's growth is attributed to the Increasing implementation of various tobacco control programs, high expenditure in healthcare and wellness by the countries in the region and launch of new and innovative products by market players for smoking cessation are some of the factors likely to drive the Smoking Cessation Aids market in the region. According to CDC, in 2017, 14 of every 100 US adults aged 18 years or older (14.0%) currently smoke cigarettes. This hints at a high usage of de-addiction products. Also, this depicts the growing awareness of the people and their readiness to quit smoking. There are also non-government and government establishments working to educate and help people quit smoking that is engaged dedicatedly, to bring the number of smokers down.

The global Smoking Cessation Aids market based on product is segmented into nicotine replacement therapy, drugs, electronic cigarettes, and others. In 2021, the electronic cigarettes segment held the largest share of the market, by product. The electronic cigarettes segment of Smoking Cessation Aids Market is also expected to witness fastest CAGR during 2021 to 2028.The increasing number of campaigns to reduce smoking and tobacco dependence are likely to increase the demand for the above-mentioned products. Therefore, it is expected that market is likely to propel during the forecast period.

Asia Pacific is expected to be the fastest-growing region and is likely to expand at a high growth rate due to increasing awareness about the smoking cessation and nicotine de-addiction products, and a huge population base in the region. For instance, an international collaboration of researchers, led by those from Vanderbilt University in the United States, studied the trends in tobacco use in China, Japan, South Korea, Singapore, Taiwan, and India in Tobacco Smoking and Mortality in Asia, a pooled meta-analysis published by JAMA Network in March 2019. By 2030, it is anticipated that 8.3 million fatalities would be due to smoking. China, India, and Indonesia account for half of the world's male smokers, and Asia is the world's largest tobacco user and production.

Pricing